Close

Description

Glycine max agglutinin (SBA) is isolated and purified by affinity chromatography. It consists of four subunits of identical sizes. The isoelectric point of SBA is pH 6.0, binds to α/β N-acetylgalactosamine and gfalactose. SBA is a 120 kDa glycoprotein. SBA has specificity for blood groups A1, A2, and B, and interacts better with neuramidase-treated cells than untreated cells. This Lectin has selective affinity for lymphocytes and human CD34+ hematopoietic stem cells. Immobilized conjugates of SBA are important tools for removing T-cells in bone marrow transplants.

Recommended Usage: Recommended dilutions of 0.5 – 10 μg / ml in 1XPBS. Neuraminidase treated erythrocytes will agglutinate by 1 – 10 μg / ml of SBA.

Storage Instruction: To prevent degradation and avoid repeated freeze-thaw cycles, aliquot your product into small, single-use volumes and store them at -20°C

Application

Immunohistochemistry, Immunocytochemistry, Stem cell separation, Bioconjugation, Immunofluorescence, Blotting, Glycobiology.

References

1.A. M. Calder6n de la Barca, L. Vhzquez-Moreno, & M. R. Robles-Burguefio. Active Soybean Lectin in Foods: Isolation and Quanfitation. Food Chemistry 39 (1991) 321-327.
2.Gade W, Jack MA, Dahl JB, Schmidt EL, Wold F. The isolation and characterization of a root lectin from soybean (Glycine max (L), cultivar Chippewa). J Biol Chem. 1981 Dec 25;256(24):12905-10.
3.Amit T Bondar, Shobha B Tole and Dr. Shivanand M Patil. Isolation and Purification of Lectin from Soybean (Glycine Max) Mahabeej Js-335. Journal of Pharmacognosy and Phytochemistry 2016; 5(6): 89-92.

Properties

Shelf life

2 years

Storage Temperature

-20°C

ECCN #

EAR99

Purity

Affinity purified

Appearance color

Off-white to brown

Appearance form

Lyophilized Powder

Molecular Weight

110 kDa

Abbreviation (Lectins Only):

SBA

Source

Soybean

Blood Group Specificity

A>O>B

Carbohydrate Specificity

GalNAc

Conjugate/Tag/Matrix

None

Inhibitory Carbohydrate

GalNAc

Divalent Ions

Ca++, Mn++

Cancer Biomarker

Prostate Cancer